Abstract
Purpose of Review: Stress echocardiography (SE) has clinical utility beyond its conventional use for the evaluation of myocardial ischemia. More specifically, SE has been shown to have significant clinical value in patients with valvular heart disease (VHD), hypertrophic cardiomyopathy (HCM), and congenital heart disease (CHD). Echocardiography laboratories providing services to such patient should be familiar with the principals of SE beyond coronary artery disease to ensure its optimum application and performance. Recent Findings: The increased demand for SE standardization specifically in patients with VHD instigated recent recommendations by relevant cardiology societies. Summary: This manuscript reviews the key concepts in performance and interpretation of hemodynamic SE in patients with VHD and HCM, including patient selection, stress modality of choice, and integration of all diagnostic and prognostic information.
Original language | English (US) |
---|---|
Article number | 33 |
Journal | Current Cardiovascular Imaging Reports |
Volume | 11 |
Issue number | 12 |
DOIs | |
State | Published - Dec 1 2018 |
Keywords
- Hypertrophic cardiomyopathy
- Stress echocardiography
- Valvular heart disease
ASJC Scopus subject areas
- Histology
- Applied Microbiology and Biotechnology
- Cell Biology